Humanwell Healthcare (Group) Co.,Ltd. (600079.SS)
CNY 20.9
(1.31%)
CNY 20.9
(1.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.04 Billion | 2.44 Billion | 2.17 Billion | 1.98 Billion | 2.03 Billion | 602.99 Million |
| Net Income | 2.13 Billion | 3.07 Billion | 1.81 Billion | 1.72 Billion | 1.35 Billion | -1.96 Billion |
| Depreciation & Amortization | 825.41 Million | 748.05 Million | 679.33 Million | 644.6 Million | 577.64 Million | 546.51 Million |
| Deferred income taxes | 14 Million | 149.84 Million | -11.05 Million | 20.25 Million | 13.69 Million | 29.33 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.91 Billion | -975.33 Million | -771.1 Million | -1.18 Billion | -731.93 Million | -1.5 Billion |
| Other non-cash items | 4.55 Billion | -658.62 Million | 452.38 Million | 801.56 Million | 840.63 Million | 3.52 Billion |
| Investing Cash Flow | -1.29 Billion | 1.22 Billion | -1.42 Billion | 301.67 Million | -349.11 Million | -1.01 Billion |
| Investments in PPE | -1.95 Billion | -3.11 Billion | -1.7 Billion | -1.09 Billion | -821.16 Million | -1.33 Billion |
| Acquisitions | 74.23 Million | 286.52 Million | -1.19 Million | 1.48 Billion | -82.44 Million | 373.21 Million |
| Investment purchases | -340.43 Million | -181.96 Million | -383.22 Million | -773.61 Million | -436.85 Million | -107.39 Million |
| Sales/Maturities of investments | 898.04 Million | 3.68 Billion | 632.08 Million | 323.64 Million | 204.59 Million | 10.45 Million |
| Other Investing Activities | 29.55 Million | 552.25 Million | 35.15 Million | 366.72 Million | 786.75 Million | 45.95 Million |
| Financing Cash Flow | -2.11 Billion | -4.24 Billion | -913.99 Million | 200.12 Million | -2.67 Billion | -705.44 Million |
| Debt repayment | -685.96 Million | -10.49 Billion | -11.39 Billion | -9.82 Billion | -11.93 Billion | -8.16 Billion |
| Dividends payments | -261.17 Million | -244.72 Million | -160.95 Million | -66.95 Million | -87.15 Million | -1.04 Billion |
| Common Stock Repurchased | -3.89 Million | -4.63 Million | - | -450.12 Million | -49.99 Million | - |
| Common Stock Issuance | -18.64 Million | 4.63 Million | - | 450.12 Million | 49.99 Million | - |
| Other Financing Activities | -1.16 Billion | 6.86 Billion | 11.15 Billion | 10.73 Billion | 10.24 Billion | 8.5 Billion |
| Accounts receivables | -1.07 Billion | -916.36 Million | -905.4 Million | -596.31 Million | -182.93 Million | -1.51 Billion |
| Accounts payables | -643.32 Million | 151.96 Million | 905.4 Million | 596.31 Million | 182.93 Million | - |
| Inventory | -200.36 Million | -360.78 Million | -486.24 Million | -78.56 Million | -204.63 Million | -450.16 Million |
| Other working capital | -1.00 | 149.84 Million | -284.86 Million | -1.1 Billion | -527.29 Million | -1.05 Billion |
| Cash at beginning of period | 5.17 Billion | 4.86 Billion | 5.04 Billion | 2.56 Billion | 3.51 Billion | 3.93 Billion |
| Cash at end of period | 4.1 Billion | 4.33 Billion | 4.86 Billion | 5.04 Billion | 2.56 Billion | 2.74 Billion |
| Capital Expenditure | -1.95 Billion | -3.11 Billion | -1.7 Billion | -1.09 Billion | -821.16 Million | -1.33 Billion |
| Effect of forex changes on cash | 16.29 Million | 48.45 Million | -24.95 Million | -105.99 Million | 42.98 Million | 38.97 Million |
| Net cash flow / Change in cash | -1.07 Billion | -528.62 Million | -180.35 Million | 2.48 Billion | -954.62 Million | -1.18 Billion |
| Free Cash Flow | 89.36 Million | -672.27 Million | 475.78 Million | 890.55 Million | 1.21 Billion | -731.65 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 478.59 Million | 624.7 Million | 486.39 Million | 2.13 Billion | 365.77 Million | 444.89 Million |
| Depreciation & Amortization | - | 241.75 Million | 241.75 Million | 825.41 Million | 221.04 Million | -331.11 Million |
| Deferred income taxes | - | - | - | 14 Million | - | -1.29 Billion |
| Stock-based compensation | - | 11.12 Million | - | - | - | -28.47 Million |
| Change in working capital | - | -909.94 Million | - | -1.91 Billion | -1.22 Billion | 1.65 Billion |
| Other non-cash items | 169.25 Million | 668.85 Million | -664.2 Million | 4.55 Billion | 1.66 Billion | 145.17 Million |
| Investing Cash Flow | -105.61 Million | -258.47 Million | -346.35 Million | -1.29 Billion | -490.19 Million | 174.72 Million |
| Investments in PPE | -256.36 Million | -216.81 Million | -321.69 Million | -1.95 Billion | -500.52 Million | -580.35 Million |
| Acquisitions | 78.25 Million | 8.23 Million | -31.73 Million | 74.23 Million | 9.65 Million | 15.47 Million |
| Investment purchases | - | - | -5 Million | -340.43 Million | -59.63 Million | 7.26 Million |
| Sales/Maturities of investments | 54.19 Million | 26.43 Million | 1.68 Million | 898.04 Million | 11.72 Million | 721.42 Million |
| Other Investing Activities | 18.29 Million | -49.89 Million | 12.08 Million | 29.55 Million | 48.58 Million | 10.91 Million |
| Financing Cash Flow | -223.87 Million | -709.46 Million | -36.27 Million | -2.11 Billion | -1.2 Billion | -285.62 Million |
| Debt repayment | -99.23 Million | -13.5 Million | -298.96 Million | -685.96 Million | -763.24 Million | -1.78 Billion |
| Dividends payments | -750.83 Million | -750.83 Million | -224.03 Million | -261.17 Million | -261.17 Million | -87 Million |
| Common Stock Repurchased | - | -1.24 Million | - | -3.89 Million | -3.89 Million | - |
| Common Stock Issuance | - | - | - | -18.64 Million | -35.62 Million | - |
| Other Financing Activities | -34.88 Million | 54.88 Million | -335.24 Million | -1.16 Billion | -177.86 Million | 1.59 Billion |
| Accounts receivables | - | -699.68 Million | - | -1.07 Billion | -1.07 Billion | 1.68 Billion |
| Accounts payables | - | - | - | -643.32 Million | - | 28.47 Million |
| Inventory | - | -221.38 Million | - | -200.36 Million | -200.36 Million | -35.84 Million |
| Other working capital | - | 11.12 Million | - | -1.00 | 43.18 Million | -28.47 Million |
| Cash at beginning of period | 2.52 Billion | 3.53 Billion | 4.1 Billion | 5.17 Billion | 4.57 Billion | 3.19 Billion |
| Cash at end of period | 2.78 Billion | 3.55 Billion | 3.53 Billion | 4.1 Billion | 4.1 Billion | 3.66 Billion |
| Capital Expenditure | -256.36 Million | -216.81 Million | -321.69 Million | -1.95 Billion | -500.52 Million | -580.35 Million |
| Effect of forex changes on cash | -51.12 Million | 7.02 Million | 1.75 Million | 16.29 Million | -2.99 Million | -6.19 Million |
| Net cash flow / Change in cash | 266.18 Million | 18.43 Million | -568.45 Million | -1.07 Billion | -466.77 Million | 471.36 Million |
| Free Cash Flow | 391.48 Million | 834.99 Million | -499.5 Million | 89.36 Million | 522.49 Million | 8.1 Million |
PERSISTENT
LIS
2397
4323
CAZ
084110